Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dosage vs Medium-dosage CoronaVac Booster in Healthy Adults
NCT05079217Phase 4Unknown
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2021
- Primary completion
- Dec 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of coronavac in coronavirus disease 2019 (COVID-19), sponsored by Sinovac Biotech Ltd.. Status: unknown.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05079217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05079217.